|
NCAPH expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.565800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.587800E-01 |
| Normal-vs-Stage2 |
8.887900E-02 |
| Normal-vs-Stage3 |
6.904600E-01 |
| Normal-vs-Stage4 |
9.763400E-01 |
| Stage1-vs-Stage2 |
1.94799999997386E-06 |
| Stage1-vs-Stage3 |
3.718000E-01 |
| Stage1-vs-Stage4 |
8.788600E-01 |
| Stage2-vs-Stage3 |
1.397350E-03 |
| Stage2-vs-Stage4 |
7.720900E-03 |
| Stage3-vs-Stage4 |
5.079400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.846600E-01 |
| Normal-vs-AfricanAmerican |
4.420600E-01 |
| Normal-vs-Asian |
8.496000E-01 |
| Caucasian-vs-AfricanAmerican |
1.072240E-01 |
| Caucasian-vs-Asian |
7.484200E-01 |
| AfricanAmerican-vs-Asian |
3.652000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.539800E-01 |
| Normal-vs-Female |
7.246600E-01 |
| Male-vs-Female |
6.544200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.951800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.438800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.884000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.548000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.223500E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.541000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.434400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.435400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.405820E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.698390E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.609200E-01 |
| Classical-VS-Follicular |
2.9972000437084E-09 |
| Classical-VS-Other |
4.594000E-01 |
| Classical-VS-Normal |
9.355200E-01 |
| Tall-VS-Follicular |
2.398100E-04 |
| Tall-VS-Other |
2.132800E-01 |
| Tall-VS-Normal |
4.809000E-01 |
| Follicular-VS-Other |
2.522600E-01 |
| Follicular-VS-Normal |
6.542200E-02 |
| Other-VS-Normal |
4.964400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.951400E-01 |
| Normal-vs-N1 |
6.617600E-01 |
| N0-vs-N1 |
6.340000E-01 |
|
|
